FDA Panel Approves Diabetes Drug Exubera
9th Sep 2005, 01:08 GMT
Pfizer's Exubera got a boost as an FDA panel recommended approval of the potential blockbuster, an inhaled form of insulin.
Latest news from WSJ.com: What's News US:
- Toyota Races to Rev Up Production
- Hospitals Aim for Better Response Times
- Renewable Fuels May Provide 25% of U.S. Use
- Gunmen Kidnap 150 From Iraqi Institute
- China Indicates Relaxing of Film Restrictions
- U.S. Ships Encounter Chinese Submarine
- Euro-Zone Economy Slows in 3rd Quarter
- Stocks Turn Higher
- Supreme Court Splits on Jury Instruction
- DaimlerChrysler Suspends Executives